| |
| |
|
| Insider
Information: |
Dunne Michael W. |
| Relationship: |
Director |
| City: |
Morristown |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
113,754 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$176,319 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
113,754 |
|
|
| Total
Value |
$176,319 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
1
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
3
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 15.3%
|
 -66.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Durata Therapeutics, Inc. |
DRTX |
Chief Medical Officer |
2014-11-17 |
0 |
2012-07-24 |
0 |
Premium* |
|
|
Iterum Therapeutics Plc |
ITRM |
Director |
2023-12-22 |
113,754 |
2018-05-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-12-22 |
4 |
B |
$1.40 |
$35,000 |
D/D |
25,000 |
113,754 |
2.39 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-12-18 |
4 |
B |
$1.84 |
$18,442 |
D/D |
10,000 |
88,754 |
2.39 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-11-22 |
4 |
B |
$2.03 |
$40,690 |
D/D |
20,000 |
78,754 |
2.39 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,487 |
58,754 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,779 |
55,267 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,853 |
53,488 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-04-01 |
4/A |
OE |
$0.00 |
$0 |
D/D |
1,299 |
37,635 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
761 |
36,337 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-09-07 |
4 |
B |
$2.22 |
$22,200 |
D/D |
10,000 |
35,576 |
2.39 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-06-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,798 |
383,647 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-03-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,494 |
346,849 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2021-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
336,355 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2021-01-26 |
4 |
S |
$1.73 |
$57,337 |
D/D |
(33,143) |
256,355 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2021-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
289,498 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Scientific Officer |
• – – |
2020-10-27 |
4 |
B |
$0.00 |
$0 |
D/D |
61,540 |
209,498 |
2.66 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Scientific Officer |
• – – |
2018-09-04 |
4 |
B |
$10.00 |
$5,000 |
D/D |
500 |
147,958 |
2.74 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Scientific Officer |
• – – |
2018-08-27 |
4 |
B |
$10.00 |
$5,000 |
D/D |
500 |
147,458 |
2.74 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Scientific Officer |
• – – |
2018-08-24 |
4 |
B |
$10.00 |
$5,000 |
D/D |
500 |
146,958 |
2.74 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Scientific Officer |
• – – |
2018-05-30 |
4 |
B |
$13.00 |
$26,000 |
D/D |
2,000 |
146,458 |
2.74 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Scientific Officer |
• – – |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
19,697 |
144,458 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2014-11-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,220) |
0 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2012-07-24 |
5 |
B |
$9.00 |
$18,000 |
D/D |
2,000 |
13,220 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2012-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
11,220 |
11,220 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
